NIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom; Chelsea & Westminster Hospital NHS Foundation Trust, London, United Kingdom.
NIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, United Kingdom; Sherwood Forest Hospitals NHS Foundation Trust, Sutton-in-Ashfield, United Kingdom.
Ann Thorac Surg. 2013 Oct;96(4):1488-1491. doi: 10.1016/j.athoracsur.2013.03.108.
The current standard therapy for patients with giant bullae is surgical bullectomy; however, high operative risk and comorbidities preclude surgical procedures in many patients. Autologous blood instilled directly into bullae can induce an inflammatory reaction, leading to scarring, fibrosis, and ultimately volume loss. We have treated 5 patients with this minimally invasive approach as day-case procedures using moderate sedation. Three of the 5 patients had shrinkage of the bullae, leading to large and clinically meaningful improvements in lung function, exercise capacity, and quality of life 3 months after treatment.
目前,大疱性肺气肿患者的标准治疗方法是手术肺减容术;然而,由于手术风险高和合并症,许多患者不能进行手术。将自体血液直接注入大疱中会引起炎症反应,导致瘢痕形成、纤维化,最终导致体积减少。我们采用这种微创方法,对 5 例患者进行了日间手术治疗,使用中度镇静。5 例患者中有 3 例大疱缩小,治疗 3 个月后,肺功能、运动能力和生活质量有了显著改善。